Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities

Overview of attention for article published in Respiratory Research, April 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 10,355 followers.

Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities https://t.co/ZgLAkwGMzM

RT @RespiratoryBMC: New article: Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have c…

RT @RespiratoryBMC: New article: Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have c…

RT @RespiratoryBMC: New article: Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have c…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.